About
Technology
Issues
FAQ
Links
Official Page
The Safety and Efficacy of Apixaban (Eliquis) in 5017 Post-bariatric Patients with 95.3% Follow-up: a Multicenter Study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.